Granules India CFO Sandip Neogi resigns
The company is in the process of appointing a new CFO.
The company is in the process of appointing a new CFO.
The company's long-term strategy is on science, technology and innovation and the company's strategy relating to this is on track
The two overhead tanks commissioned at a cost of Rs 57 lakh will be maintained by the village panchayats.
Granules now have a total of 51 ANDA approvals from US FDA (49 Final approvals and 2 tentative approvals).
Pharmaceutical manufacturer uses Veeam solutions to accelerate mission-critical backups by 95% and restore data in minutes, not hours
Granules India has reported consolidated financial results for the period ended December 31, 2021
The company posted net profit of Rs.111.44 crores for the period ended June 30, 2020.
The US FDA has closed the observations pertaining to this audit with an Establishment Inspection Report on the 20th of July 2021
The company will provide one crore tablets every week, starting from 12th May 2021, aggregating to 16 crore tablets worth Rs. 8 crores over the next 4 months
ranules now has a total of 38 ANDA approvals from US FDA.
Subscribe To Our Newsletter & Stay Updated